Deutsche Bank Says Nu Skin (NUS) Attacks 'Unfounded and Misguided'

March 5, 2013 1:28 PM EST
Get Alerts NUS Hot Sheet
Price: $51.60 --0%

Rating Summary:
    6 Buy, 5 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 7 | Down: 8 | New: 1
Trade NUS Now!
Join SI Premium – FREE
Deutsche Bank today reiterated a Buy rating on Nu Skin Enterprises (NYSE: NUS) with price target of $60.00. Analysts called recent attacks on the stock "unfounded and misguided" and see upside from current valuation.

"Company is one of the few growth names in our group, successfully lapping increasingly difficult comparisons with better than expected results and likely to deliver high single to low double-digit growth again in 2013," said analyst Bill Schmitz Jr.

"According to the company, FTC has been following the industry for a long time since the 1990s and there have been no recent contacts or questions from them. There has also been no impact so far on sales force in the US or elsewhere from any negative headlines out of Wall Street," added the analyst, referring to recent press coverage related to Herbalife (NYSE: HLF).

For an analyst ratings summary and ratings history on Nu Skin Enterprises (NYSE: NUS) click here. For more ratings news on Nu Skin Enterprises click here.

Shares of Nu Skin Enterprises closed at $42.56 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS View

Related Entities

Deutsche Bank

Add Your Comment